Cardiovascular diseaseCardiovascular disease is the umbrella term for problems with the heart and blood vessels, including heart attacks, strokes, and blocked leg arteries. (CVD) remains the most formidable public health challenge of the modern era, standing as the leading cause of global mortality and accounting for approximately one-third of all deaths worldwide.[1] The canonical understanding of atherosclerosisAtherosclerosis is the disease behind most heart attacks and many strokes. Cholesterol particles get stuck in the wall of an artery, the body sends immune cells to clean up, and over years that mess hardens into plaque.—the progressive, insidious narrowing and hardening of arterial vessels via fibrofatty plaquePlaque is the buildup of cholesterol, immune cells, scar tissue, and calcium inside an artery wall. deposition—attributes the pathogenesis to a constellation of well-established, predominantly modifiable risk factorsA risk factor is something that raises your chance of developing a disease — high cholesterol particles, high blood pressure, smoking, diabetes, family history.. These classical determinants include systemic hypertensionHypertension is the medical term for high blood pressure., dyslipidemiaDyslipidemia is the medical word for an unhealthy pattern of fats in the blood. It can mean high LDL, high triglycerides, low HDL, or some combination. (specifically elevated low-density lipoproteinA lipoprotein is a tiny package that carries fat and cholesterol through your bloodstream. Since fat won't dissolve in water, it needs a protein wrapper to travel. cholesterolCholesterol is a waxy substance your body needs. It goes into cell walls, hormones, vitamin D, and the bile that digests your food. You would die without it.), type 2 diabetesDiabetes is a condition where blood sugar stays too high, either because the body makes too little insulin or because it stops responding to the insulin it makes. mellitus, obesityObesity means carrying enough excess body fat to affect health., physical inactivity, advancing age, and tobacco consumption.[1] However, a persistent and deeply confoundingConfounding is when a hidden third factor makes two unrelated things look connected. epidemiological paradox has long challenged the absolute comprehensiveness of this traditional paradigm: approximately 15% of first-time cardiovascular disease events, including catastrophic myocardial infarctionsSee Heart Attack for the full entry. and cerebrovascular accidents, occur in patients who present with a complete and absolute absence of these established risk factors.[1]

This profound clinical anomaly is further complicated and illuminated by the field of cross-species comparative cardiology. When observing the broader mammalian kingdom, naturally occurring coronary thromboses and myocardial infarctions driven by atheromatous plaque rupturePlaque rupture is when the protective cap over a plaque tears open, spilling its contents into the bloodstream. are virtually non-existent in species other than humans.[1] This resistance holds remarkably true even in our closest evolutionary relatives, the non-human hominids. Captive chimpanzees frequently share human-like sedentary lifestyles and display strikingly analogous physiological derangements, including profound hyperlipidemia, advanced age, and systemic hypertension.[1] Yet, despite possessing human-like CVD-risk-prone blood lipid profilesA blood test panel that measures total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides, used to assess cardiovascular risk and monitor the effect of dietary or drug interventions. and evidence of mild, early-stage atherosclerosis, these primates rarely suffer from terminal atherosclerotic CVD events.[2] When catastrophic cardiac eventsClinically significant heart-related occurrences—including myocardial infarction, unstable angina, and cardiac death—used as outcome endpoints in cardiovascular trials. do occur in chimpanzee populations, rigorous post-mortem analyses reveal that their heart attacksA heart attack happens when blood flow to part of the heart muscle is cut off and that muscle starts to die. are overwhelmingly driven by an as-yet unexplained interstitial myocardial fibrosisInterstitial myocardial fibrosis is the diffuse scarring and replacement of heart muscle cells with fibrous connective tissue throughout the myocardium; in chimpanzees, fatal cardiac events are caused by this process rather than by atheromatous plaque rupture, distinguishing their heart disease pattern from that of humans.—a diffuse scarring of the heart muscle—rather than the canonical atheromatous plaque rupture and subsequent thrombosisThrombosis is a blood clot forming inside a blood vessel. seen in human patients.[2] Furthermore, while heavy red meatRed meat includes beef, pork, and lamb. consumption is a universally recognized epidemiological amplifier of CVD risk in human populations, this exact dietary pattern does not provoke atherogenesisAtherogenesis is the step-by-step process of a plaque forming. in other carnivorous or omnivorous mammals.[2]

This profound divergence points inexorably toward a species-specific, intrinsic genetic predisposition to atherosclerosis in humans.[1] The crux of this unique vulnerability lies not strictly in lipid metabolism, hemodynamic shear stress, or behavioral variables alone, but in an ancient evolutionary genetic anomaly involving the fundamental biology of cell-surface glycansA carbohydrate chain or sugar molecule attached to proteins or lipids on cell surfaces; Neu5Gc is incorporated into human cell-surface glycans after red meat consumption, where it is recognized by the immune system as foreign.. Specifically, human cardiovascular susceptibility is inextricably linked to an evolutionary loss of the ability to synthesize N-glycolylneuraminic acid (Neu5Gc)A non-human sialic acid sugar molecule found on the cell surfaces of most mammals, including cattle, pigs, and sheep, but not synthesized by humans; it can be absorbed from red meat and incorporated into human tissues, where it may trigger an immune response., a ubiquitous mammalian sialic acid.[1] Despite this profound genetic deficiency, human consumption of Neu5Gc-rich red meat results in the metabolic incorporation of this non-human glycan directly into human tissues, most notably the vascular endotheliumThe endothelium is the ultra-thin, slippery lining on the inside of every blood vessel. It is only one cell thick..[3,4] The subsequent immunological recognition of this incorporated sugar as a “xeno-autoantigenA xeno-autoantigen is a foreign molecule that, once incorporated into the body's own tissues, is targeted by the immune system as if it were both self and non-self simultaneously; Neu5Gc functions as a xeno-autoantigen when it is metabolically embedded into the human vascular endothelium after red meat consumption.” triggers a chronic, smoldering inflammatory cascade termed “xenosialitisXenosialitis is a state of chronic, smoldering vascular inflammation that arises when dietary Neu5Gc from red meat is incorporated into human endothelial tissue and subsequently attacked by the body's own anti-Neu5Gc antibodies, which recognize it as a foreign 'xeno-autoantigen.'.”[5]

This exhaustive research report elucidates the highly intricate evolutionary, biochemical, and immunological mechanisms underpinning the xenosialitis hypothesis. By exploring the genomic deletion of the CMAH geneThe gene encoding the enzyme CMP-N-acetylneuraminic acid hydroxylase, which converts Neu5Ac to Neu5Gc in most mammals; humans carry an inactivating mutation in this gene and therefore cannot synthesize Neu5Gc., the complex microbiome-mediated digestion of dietary Neu5GcNeu5Gc is a sugar molecule found in red meat. Humans lost the ability to make it millions of years ago, but we still absorb it when we eat beef, pork, or lamb., the molecular hijacking of human intracellular glycosylation pathways, and the resultant polyclonal antibody-mediated endothelial destruction, this analysis provides a comprehensive understanding of why humans are uniquely susceptible to red meat-associated atherosclerosis, and precisely how this mechanism quantifiably escalates cardiovascular risk across the lifespan.

The Evolutionary Paradigm: The CMAH Gene Mutation and Human Origins

The Fundamental Biology of Sialic Acids

To accurately comprehend the magnitude and consequence of the human genetic defect, one must first establish the physiological and structural role of sialic acidsSialic acids are a family of nine-carbon monosaccharides that cap the outermost ends of cell-surface glycan chains; their strong negative charge and exposed position make them key mediators of immune self-recognition, pathogen binding, and endothelial stability. within vertebrate biology. The surfaces of all vertebrate cells are intimately decorated with a dense, complex, and highly regulated array of sugar chains, which are predominantly attached to integral membrane proteinsProtein is the nutrient your body uses to build and repair muscle and tissue. and surface lipids to form the glycocalyxThe glycocalyx is a delicate sugar-rich coating on the inner surface of blood vessels, a kind of gel layer between the blood and the cells..[6,7] Most soluble secreted proteins traversing the human circulation are also similarly decorated with such specialized glycans.[6,7] Sialic acids represent a diverse family of highly modified monosaccharides built upon a nine-carbon backbone, and they are typically found capping the outermost, terminal ends of these glycan chains.[6,7]

Due to their distal location on glycoproteins and glycolipids, combined with their strong electronegative charge at physiological pH, sialic acids play indispensable and multifaceted roles in mediating cell-to-cell adhesion, modulating receptor-ligand interactions, stabilizing the endothelial glycocalyxThe endothelial glycocalyx is a thin, gel-like layer of glycoproteins and proteoglycans lining the inner surface of blood vessels; it acts as a selective barrier that limits direct contact between circulating lipoproteins and the arterial wall, and is vulnerable to disruption by disturbed or high-velocity blood flow. barrier, and regulating immune self-recognition via specific sialic acid-binding lectins (Siglecs).[6,8]

In the vast majority of mammalian species, and indeed across most terrestrial vertebrates, the two predominant forms of sialic acid are N-acetylneuraminic acid (Neu5Ac) and its direct hydroxylated derivative, N-glycolylneuraminic acid (Neu5Gc).[6,7] These two molecules are structurally nearly identical, differing by the presence of only a single oxygen atom.[5] The biochemical transition from the precursor Neu5Ac to the derivative Neu5Gc is catalyzed exclusively by a single, highly specific enzyme: cytidine monophosphate-N-acetylneuraminic acid hydroxylase (CMAH).[1,3] This critical enzyme acts upon the nucleotide-sugar donor CMP-Neu5Ac within the cellular cytosol, facilitating a mono-oxygenase reaction that adds a hydroxyl group to generate CMP-Neu5Gc.[6,7] Both CMP-Neu5Ac and CMP-Neu5Gc are subsequently transported from the cytosol into the lumenThe lumen is the open channel inside a blood vessel where blood actually flows. of the Golgi apparatus, where they serve as the primary nucleotide-sugar donors for addition to newly synthesized glycoconjugatesGlycoconjugates are molecules—typically proteins (glycoproteins) or lipids (glycolipids)—to which sugar chains are covalently attached; sialic acids, including Neu5Gc from dietary red meat, are added to glycoconjugates in the Golgi apparatus and then displayed on cell surfaces..[6,7] Consequently, normal mammalian tissues exhibit a rich, interspersed, and highly functional mosaic of both Neu5Ac and Neu5Gc on their cellular surfaces.[6,7]

The Alu-Mediated Pseudogenization Event

Humans, however, represent a stark and consequential anomaly within the mammalian lineage. Normal, healthy human tissues are genetically and fundamentally incapable of synthesizing Neu5Gc.[5] This biochemical truncation is not a regulatory suppression, but the direct consequence of a species-specific, irreversible mutation within the CMAH gene itself.[1,3]

Paleogenomic estimates and comparative phylogenetic analyses indicate that approximately 2 to 3 million years ago—a temporal epoch corresponding to the emergence of the genus Homo from our hominin ancestors—a critical genomic event occurred.[1,9,12] An Alu transposable elementAn Alu element is a type of short, repetitive 'jumping gene' abundant in primate genomes that can insert itself into new genomic locations; the insertion of an Alu element into the CMAH locus caused the 92-base-pair deletion that permanently inactivated Neu5Gc synthesis in ancestral humans., a type of “jumping gene” common in primate genomes, inserted itself into the CMAH genetic locus. This insertion mediated a catastrophic frame-shift deletion of a critical 92-base-pair exon within the CMAH gene, resulting in a premature stop codon and the total pseudogenizationPseudogenization is the mutational inactivation of a gene so that it can no longer produce a functional protein; the CMAH gene in humans underwent pseudogenization via a frameshift deletion, leaving an intact but nonfunctional gene sequence inherited by all modern humans. (complete inactivation) of the locus.[9,12] Because the enzymatic reaction from CMP-Neu5Ac to CMP-Neu5Gc is strictly unidirectional and reliant entirely on CMAH, the loss of this single enzyme permanently severed the biosynthetic pathway.[1,3] As a direct result, modern humans produce only the precursor, Neu5Ac, leaving their cellular surfaces completely devoid of endogenous Neu5Gc and dramatically altering the biochemical landscape of the human organism.[1,3]

Evolutionary Selection Pressures: Pathogens and Reproductive Isolation

The fixation of a loss-of-function mutation in a gene responsible for the synthesis of a primary, ubiquitous cell-surface molecule is an extraordinary evolutionary event. Such a drastic and sudden alteration in the host glycocalyx must have been driven by phenomenally intense evolutionary selection pressures, as stochastic genetic drift alone is highly unlikely to account for the complete, population-wide fixation of such a fundamental biochemical change.[12] Current evolutionary biology posits a multi-factorial model for the rapid fixation of the CMAH null allele in the ancestral hominin population.

The leading, and most aggressively researched, hypothesis involves a brutal host-pathogen evolutionary arms race, specifically involving the ancestors of the malaria-causing Plasmodium parasites.[9,12] Mammalian cell-surface sialic acids serve as the primary docking receptors and recognition motifs for various viral, bacterial, and parasitic pathogens.[6,7] It is highly probable, based on genomic signatures of selection, that ancestral hominins were decimated by a highly virulent strain of “non-human hominid” (NHH) malaria that preferentially bound to Neu5Gc-rich erythrocytes to gain cellular entry.[9,12] The Alu-mediated loss of the CMAH gene, while potentially deleterious in other respects, provided a sudden, life-saving survival advantage to the rare individuals carrying the mutation. By effectively stripping the host of the pathogen’s preferred cell-surface receptor, the CMAH-deficient hominins were able to escape the prevailing malarial scourge, leading to a massive selective sweep that fixed the null mutation across the surviving population.[9,12] This evolutionary victory, however, was temporary in the grand scope of deep time. Plasmodium falciparum—the highly lethal agent responsible for modern human malignant malaria—eventually evolved the capacity to bind preferentially to the newly ubiquitous, human-specific Neu5Ac-rich erythrocytes, re-establishing the host-pathogen dynamic.[6,7,12]

A secondary, yet equally compelling and complementary hypothesis involves reproductive isolation and “catastrophic selection” mediated by the female immune system.[12] Mammalian spermatozoa are heavily sialylated, utilizing complex surface glycans to enhance sperm survival, mask immunogenic proteins, and optimize function along the perilous journey through the female reproductive tract to the site of fertilization in the oviduct.[12] A female hominin carrying the rare CMAH-null mutation would naturally develop circulating anti-Neu5Gc antibodies upon post-natal exposure to environmental or dietary Neu5Gc, as her immune system would recognize the molecule as non-self.[10,12,18] If this mutant female subsequently mated with a wild-type (CMAH-positive) male, her circulating antibodies would aggressively target and neutralize the Neu5Gc-rich paternal sperm, severely depressing his reproductive success and effectively destroying the viability of the pairing.[12] Over thousands of generations, this female immune-mediated selection against paternal Neu5Gc would create an intense, unyielding reproductive barrier between mutant and wild-type populations, driving the rapid fixation of the CMAH-null genotype and potentially contributing directly to the speciation event that ultimately isolated human ancestors from other hominids.[12]

The Dietary Mismatch: Digestion and Microbial Processing of Exogenous Sialic Acids

The evolutionary loss of the CMAH gene renders Neu5Gc biochemically completely foreign to the modern human organism.[5] Yet, despite this profound genetic deficiency, modern human diets—particularly in Westernized societies—are replete with this molecule. Neu5Gc is highly concentrated in red meats derived from mammalian sources, specifically beef, pork, and lamb, which remain staples of global consumption.[3,8,22] Furthermore, dairy products derived from these mammals also contain measurable, though lesser, quantities of the non-human sialic acid.[8]

Rigorous biochemical assays and high-performance liquid chromatography have clearly defined the dietary landscape of Neu5Gc exposure. Research demonstrates that beef contains the absolute highest levels of the molecule, harboring approximately 30.1 µg/g of Neu5Gc, followed closely by pork at 25.5 µg/g.[7,8] Conversely, avian species (such as poultry) and diverse fish lineages diverged from the mammalian tree long before the evolution of the CMAH gene, or independently lost it, and are therefore completely and natively devoid of Neu5Gc.[7,8] This strict biochemical dichotomy makes dietary Neu5Gc exposure highly specific to mammalian red meat consumption.[7,8]

The Critical Role of the Gut Microbiome

The transition of dietary Neu5Gc from a consumed foodstuff resting in the gastric lumen to an absorbed, systemically active biochemical entity is tightly regulated by the host gastrointestinal microbiome. Dietary Neu5Gc is not generally ingested as a free monosaccharide; rather, it is consumed primarily in a glycosidically bound form, integrated deeply into the complex glycoproteins, mucins, and glycolipids that comprise mammalian tissue (such as porcine submaxillary mucin).[8,17] This distinction between bound and free sialic acid is of paramount physiological importance. While free, un-bound Neu5Gc can technically be absorbed across the intestinal barrier, it is recognized by the body as a small, highly soluble, and non-utilizable molecule. Consequently, free Neu5Gc is rapidly cleared by the renal system and excreted efficiently in the urine, completely failing to cause long-term tissue accumulation or pathology.[11,16] It is only the structurally bound Neu5Gc, presented in complex macromolecular arrays, that undergoes the dangerous process of metabolic incorporation.[11,16,17]

Recent advances in metagenomic sequencing of the human and murine gut microbiomeThe gut microbiome is the enormous community of bacteria living in your intestines. There are trillions of them, and they are not passive passengers. have revealed that the resident microbial flora dynamically and rapidly responds to a Neu5Gc-rich diet.[17] Specifically, populations belonging to the orders Bacteroidales and Clostridiales undergo significant phenotypic expansion when exposed to red meat-associated carbohydratesCarbohydrates are the sugars and starches in food — bread, rice, pasta, fruit, potatoes, sweets..[17] These specific bacterial clades have evolved to express highly specialized bacterial sialidases (neuraminidases) designed specifically to cleave terminal sialic acids from host mucosal mucins and, crucially, from dietary glycoproteins.[17,20,21]

Historically, it was assumed that bacterial sialidases exclusively preferred the host-endogenous Neu5Ac, as this is the most abundant substrate in the human gut. However, profound structural studies utilizing advanced X-ray crystallography have identified specific, previously unobserved amino acid configurations within certain bacterial sialidases that confer an unusually high-affinity substrate preference for Neu5Gc-containing glycans.[17] These specialized gut microbes orchestrate a complex cross-feeding dynamic within the microbiome, wherein they utilize the Nan genetic pathway to actively catabolize the cleaved sialic acids for energy and carbon sourcing.[20,21] Interestingly, the downstream catabolism of Neu5Ac produces acetic acid as a byproduct, whereas the bacterial metabolism of Neu5Gc yields glycolic acid.[20,21] These differences in metabolic byproducts may subtly alter the local pH and metabolic landscape of the colonic epithelium, contributing to the broader inflammatory milieu.[20,21]

The enzymatic liberation of Neu5Gc by these microbial sialidases from the massive meat glycoproteins into smaller, specific oligosaccharide fragments (such as GalNGc) is heavily suspected to be the requisite first step for the subsequent intestinal absorption and systemic distribution of the non-human sugar.[8,17]

Cellular Hijacking: The Mechanism of Metabolic Incorporation

Once dietary, glycosidically-bound Neu5Gc (or its microbiome-liberated oligosaccharide intermediates) transverses the complex intestinal epithelium, it enters the systemic circulation. Evidence demonstrates that following a red meat meal, these xeno-glycans appear in the human circulation at a steady-state level that persists for several hours, providing ample opportunity for tissue interaction.[11,15,16] The phenomenon by which this completely foreign dietary molecule is permanently integrated into human tissues represents a fascinating and highly dangerous vulnerability in human biochemistry. The fundamental issue is one of molecular deception: our highly conserved intracellular glycosylation machinery simply cannot distinguish between the endogenous precursor (Neu5Ac) and the exogenous, non-human analog (Neu5Gc).[3,5,11] The molecules, differing by only a single, tiny oxygen atom, appear identical to the enzymes responsible for cellular construction.[3,5]

The Endocytic and Lysosomal Pathway

Because human cells completely lack a dedicated plasma membrane transporter specifically designed for the uptake of free sialic acids from the extracellular space, the internalization of circulating Neu5Gc-glycoconjugates must occur via alternative routes.[11,13,16] This uptake is driven primarily by fluid-phase endocytosis and macropinocytosis—processes where the cell essentially “drinks” the surrounding extracellular fluid and its dissolved contents.[11,12,16]

Upon internalization, these exogenous molecules are encapsulated in endosomes and carefully trafficked to the highly acidic, degradative environment of the lysosome.[11,16] Within the lysosome, host-derived lysosomal sialidases enzymatically cleave the complex dietary glycoconjugates, finally releasing free Neu5Gc monosaccharides deep within the cell.[11,16]

The critical, irreplaceable gateway for the subsequent incorporation of this molecule is the lysosomal sialic acid transporter, a protein known as sialin (encoded by the SLC17A5 gene).[11,13,16] Sialin is a highly conserved transmembrane protein whose normal physiological role is the salvage and recycling of endogenous host Neu5Ac from degraded glycoproteins in the lysosome, pumping them back into the cytosol for reuse.[11,16] However, sialin is not perfectly selective; it readily accepts the free Neu5Gc molecules derived from red meat and actively transports them into the cytosolic space, effectively breaching the cell’s final internal barrier.[11,12,16]

De Novo Synthesis and Endothelial Expression

Once within the relative safety of the cytosol, the exogenous Neu5Gc enters the host cell’s de novo sialic acid synthetic pathway, initiating the final stages of the biochemical hijacking. The molecule is acted upon by cytidine monophosphate (CMP)-sialic acid synthase, an enzyme that activates the monosaccharide by attaching a high-energy CMP nucleotide, forming the donor complex CMP-Neu5Gc.[6,7] This activated sugar-nucleotide donor is then actively transported into the lumen of the Golgi apparatus, the central sorting and modification hub of the cell.[6,7]

Within the Golgi, human glycosyltransferases—the precise enzymes responsible for building the complex, branching glycan trees on newly synthesized proteins and lipids—blindly utilize the abundant CMP-Neu5Gc donors as if they were the correct, endogenous CMP-Neu5Ac.[3,5,11] Consequently, Neu5Gc is covalently and permanently attached to newly minted glycoproteins and glycolipids. These newly assembled, xeno-sialylated molecules are then trafficked via secretory vesicles to the cell surface, where they are integrated into the plasma membrane.[3,5]

Through this intricate biochemical pathway, human cells essentially hijack a dietary compound and unwittingly weaponize their own cell surfaces. While Neu5Gc accumulation has been observed in various human tissues, including the epithelia lining hollow organs (which explains its strong epidemiological link to various carcinomas), it exhibits a profound, highly selective tropism for the vascular endothelium—the delicate, innermost lining of all blood vessels.[5,22] Rigorous immunohistochemical surveys of human autopsy samples, utilizing both highly specific, monospecific chicken anti-Neu5Gc antibodies and affinity-purified human sera, have definitively demonstrated intense Neu5Gc expression in the normal-appearing human aortaThe aorta is the biggest artery in your body. It carries blood out of the heart and down through the chest and belly, sending branches everywhere., the dense microvasculature of the colon and placenta, and crucially, in the endothelium directly overlying active atherosclerotic plaques.[5]

The Immunological Genesis: Commensal Priming and Xeno-Autoantibodies

The presence of a non-human molecule covalently bonded to human tissues poses a uniquely dangerous immunological paradox, categorized formally in the literature as a “xeno-autoantigen.”[5] Because Neu5Gc is biologically foreign (“xeno”) due to our evolutionary history, the human immune system recognizes it as foreign even though it is physically embedded within the intimate context of the host’s own self-associated molecular patterns on the endothelial surface.[5,6]

The Ontogeny of the Immune Response

Extensive immunological surveillance and epidemiological testing reveal a startling fact: essentially all normal, healthy human adults possess circulating, highly active polyclonal anti-Neu5Gc antibodies.[5,6,10] These highly diverse antibody repertoires comprise Immunoglobulin G (IgG), IgA, and IgM isotypes, targeting a wide variety of Neu5Gc-containing epitopes commonly found on human endothelial cellsThe thin layer of cells lining the inner surface of all blood vessels; they regulate vascular tone, prevent clotting, and control the passage of substances into the artery wall — and their dysfunction is an early, critical step in atherosclerosis..[5,6,10] Crucially, these antibodies are not germ-line encoded “natural” antibodies (such as those that determine the ABO blood group system, which are present independent of specific exposure).[5,10,18] Rather, they require specific postnatal antigenic stimulation and undergo classic affinity maturation to achieve their high binding capabilities.[10,18]

Detailed analyses of infant cord blood demonstrate a complete and utter absence of anti-Neu5Gc antibodies (specifically IgM) at the time of birth.[10,18] Titer levels remain undetectable for the first few months of life, strongly arguing against transplacental transfer as the primary source of long-term immunity.[10,18] However, these antibody titers begin to rise sharply and consistently around six months of age.[10,18] This precise timeline correlates perfectly with the introduction of cow’s milk-based formulas, dairy products, and the general weaning process onto solid foods, marking the infant’s absolute first systemic exposure to dietary Neu5Gc.[8,10,18] Furthermore, epidemiological studies examining broader environmental exposures have shown that children raised on active farms, who are presumably exposed to significantly higher ambient levels of animal-derived antigens, exhibit statistically higher levels of circulating anti-Neu5Gc IgG compared to non-farming, urban-dwelling children.[8,18]

Bacterial Priming via Haemophilus influenzae

A critical, mechanistic question arises: how does the human immune system mount such a robust, lifelong, affinity-matured antibody response against a simple dietary sugar, especially given that free Neu5Gc, when isolated, is only weakly immunogenic on its own?

The answer lies in the insidious phenomenon of microbial molecular mimicry and bacterial cloaking. While the genetic synthesis of endogenous Neu5Gc has never been documented in any bacterial, viral, or fungal microbe across the tree of life, certain highly adapted commensal human pathogens act as efficient molecular scavengers.[14,21] Nontypeable Haemophilus influenzae (NTHi), a ubiquitous, human-specific commensal bacterium and opportunistic respiratory pathogen responsible for otitis media and respiratory exacerbations, possesses a highly specialized tripartite ATP-independent periplasmic (TRAP) transporter.[14,21] This specific transport system efficiently scavenges trace amounts of dietary Neu5Gc from the host’s mucosal environment.[14,21]

Once scavenged from the host, NTHi metabolically incorporates this Neu5Gc directly into its own cell surface lipooligosaccharides (LOS).[14,19,21] This bacterial sialylation confers a massive, almost impenetrable survival advantage to the organism. The integration of Neu5Gc into its protective biofilm significantly increases the bacterium’s resistance to complement-mediated killing by the host’s innate immune system.[14,21] It achieves this primarily by abrogating the classical pathway of complement activation, actively preventing host IgM antibodies from binding to the bacterial surface and initiating lysis.[14,21]

However, this sophisticated bacterial cloaking mechanism comes at a severe, chronic cost to the human host. The presentation of the Neu5Gc antigen on the highly inflammatory, pathogen-associated surface of a bacterial pathogen acts as an intense, natural immunological adjuvant.[10,14,21] When the human immune system inevitably mounts a vigorous, systemic response against the NTHi bacteria to clear the infection, it simultaneously generates a vast repertoire of cross-reactive anti-Neu5Gc antibodies.[10,14,21] It is now widely accepted in the field that this post-natal, pathogen-mediated priming, operating in constant tandem with daily dietary red meat exposure, provides the requisite, highly inflammatory signal for the lifelong production and maintenance of xeno-autoantibodies.[5,10,14,18]

Xenosialitis: The Mechanics of Atherogenesis

The disastrous convergence of metabolic incorporation (providing the widespread endothelial antigen) and microbial priming (providing the circulating, high-affinity antibody) culminates in a continuous, smoldering state of vascular inflammationInflammation is your immune system's response to injury or something it treats as an invader. It brings swelling, heat, and cleanup cells. formally termed “xenosialitis.”[5] This pathological process is uniquely insidious because the antigen is continuously replenished with every red meat meal consumed over a lifetime, ensuring that the inflammatory cycle never reaches biological resolution.

The precise pathophysiology of xenosialitis, particularly in the direct context of accelerating atherosclerosis, unfolds in a highly orchestrated, sequential cascade of cellular destruction:[5]

1. Antigen-Antibody Ligation: Circulating polyclonal human anti-Neu5Gc antibodies (primarily the IgG and IgA isotypes) continuously screen the vascular endothelium as blood flows through the arterial tree. Upon encountering a metabolically incorporated Neu5Gc epitope displayed on the delicate endothelial glycocalyx, the antibodies bind with high affinity, forming a dense in situ immune complex directly on the vessel wall.[5]
2. Complement Cascade Activation: The spatial clustering of IgG and IgA molecules on the endothelial surface exposes their Fc (fragment crystallizable) regions to the bloodstream. This exposed array provides an ideal binding site for the C1q protein complex, the initiator of the complement system.[5,15] This triggers the classical complement cascade, leading to the aggressive, sub-lytic deposition of complement proteins (such as C3b and the membrane attack complex) directly onto the intact, otherwise healthy endothelium.[5]
3. Profound Endothelial Activation: The heavy deposition of complement proteins, combined with the mechanical cross-linking of surface receptors by the antibodies, forcefully pushes the endothelial cell from its normal, quiescent, non-thrombogenic state into a highly activated, pro-inflammatory phenotype.[5] Sophisticated in vitro models demonstrate that the simple incubation of high-titer human sera with Neu5Gc-fed endothelial cells directly causes massive intracellular signaling changes, resulting in the rapid exocytosis of Weibel-Palade bodies and the rapid de novo transcription of inflammatory genes.[5]
4. Cytokine Secretion and Selectin Upregulation: The newly activated endothelium begins to secrete copious amounts of pro-inflammatory cytokines, creating a localized chemotactic gradient designed to summon immune cells.[5] Simultaneously, the cells rapidly upregulate the surface expression of critical adhesion molecules, specifically E-selectin and P-selectin.[5] P-selectin, in particular, is a potent, well-recognized mediator of recurrent thromboembolism and cardiovascular disorders, operating to facilitate the initial, rolling tethering of circulating leukocytes to the vessel wall.[23]
5. Leukocyte Extravasation and Plaque Formation: The heavy presence of selectins and the disrupted glycocalyx leads to Neu5Gc-dependent monocyte binding.[5] The circulating monocytes roll along the activated endothelium, firmly adhere via integrin interactions, and actively diapedese (squeeze) into the subendothelial spaceThe subendothelial space is the narrow gap just beneath the artery's inner lining, between that single layer of cells and the muscle beneath. (the tunica intimaThe intima is the innermost layer of an artery wall, sitting just beneath the smooth lining.). Once trapped inside the arterial wall, these hyperactive monocytes transform into resident macrophagesA macrophage is a large immune cell that swallows debris and invaders. The name literally means "big eater.", begin to aggressively engulf oxidized low-density lipoproteins (LDLLDL, or low-density lipoprotein, is the main particle that carries cholesterol through your blood — and the main one that gets stuck in artery walls.), and swell into massive foam cellsA foam cell is an immune cell that has eaten so much trapped cholesterol that it swells up and looks foamy under a microscope.. The accumulation and subsequent apoptotic death of these foam cells forms the foundational, highly thrombogenic necrotic coreThe necrotic core is the dead, mushy center of an advanced plaque, built from immune cells that ate trapped cholesterol and then died in place. of the atherosclerotic plaque.[5]
6. Synergistic Amplification Loops: This destructive cascade does not operate in a vacuum; it is further amplified by systemic inflammatory states. The presence of Tumor Necrosis Factor-alpha (TNF-α), a ubiquitous, highly potent pro-inflammatory cytokine typically upregulated during flares of general vascular damage or metabolic syndromeMetabolic syndrome is a cluster of five problems that tend to travel together: a large waist, high triglycerides, low HDL, high blood pressure, and high blood sugar. Having three or more counts., selectively and powerfully enhances the reactivity of human anti-Neu5Gc antibodies, creating a compounding, positive feedback loop of vascular destruction.[5] Additionally, heme ironThe form of iron bound to hemoglobin and myoglobin in animal tissue, absorbed more efficiently than plant-derived non-heme iron; cited as one of the potentially harmful components of red meat contributing to cardiovascular and cancer risk., highly concentrated in red meat, exerts its own independent pro-inflammatory and oxidative effects that compound the endothelial distress initiated by the glycans.[22,23]

Quantifying the Risk: Incontestable Evidence from Humanized Mouse Models

To rigorously isolate, verify, and quantify the specific contribution of the CMAH evolutionary loss to cardiovascular disease—expressly separating it from the myriad confounding lifestyle factors inherent to modern human existence (such as smokingSmoking damages the lining of your blood vessels, raises blood pressure, makes blood clot more easily, and speeds up plaque growth., sedentarism, and refined sugar consumption)—researchers engineered a profound, highly specific transgenic animal model: the human-like Cmah^-/- LdlrLDLR is the gene that builds the LDL receptor, the docking port your liver uses to pull cholesterol particles out of circulation.^-/- mouse.[1]

Wild-type laboratory mice (Cmah^+/+) naturally and abundantly produce Neu5Gc and, like virtually all other mammals, do not suffer from xenosialitis.[1] To accurately recreate the human condition, researchers utilized genetic engineering to knock out both the Cmah gene (perfectly mimicking the human evolutionary loss 2 to 3 million years ago) and the Ldlr (Low-Density Lipoprotein Receptor) gene. The Ldlr knockout is a standard procedure required to induce baseline susceptibility to diet-driven atherosclerosis in mice, allowing the researchers to measure variations in plaque formation over reasonable experimental timeframes.[1]

The experimental data derived from these models yielded two distinct, highly significant quantifications of disease progression, beautifully separating the risk into two components: the intrinsic risk multiplier (the genetic penalty of being human) and the extrinsic risk multiplier (the dietary penalty of consuming red meat).

The Intrinsic Risk (The Baseline Human Penalty)

In the meticulously controlled first phase of the experiment, researchers fed both the wild-type control Cmah^+/+ mice and the human-like Cmah^-/- knockout mice an identical, highly controlled high-fat diet that was entirely devoid of all sialic acids (a Sias-free diet).[1] The results were staggering: even in the absolute, complete absence of dietary Neu5Gc, the human-like Cmah^-/- mice suffered a highly significant 1.9-fold increase in atherogenesis compared directly to the wild-type controls.[1]

This near-doubling of plaque formation in a controlled environment isolated the intrinsic biological cost of the CMAH mutation.[1] Extensive histological and biochemical analyses revealed that the loss of the gene fundamentally altered the baseline physiology of the organism. The Cmah^-/- mice exhibited highly elevated macrophage cytokine expression, rendering their white blood cells inherently hyperactive, hypersensitive, and prone to inflammatory overreactions even without a specific antigen trigger.[1] Furthermore, the mutation directly induced enhanced hyperglycemiaAbnormally elevated blood glucose concentration; included as one of the modifiable risk factors in the PDAY scoring system because it accelerates arterial lesion progression in adolescents and young adults. and a strong metabolic tendency toward diabetes, significantly elevating their HOMA-IRHOMA-IR (Homeostatic Model Assessment of Insulin Resistance) is a calculated index derived from fasting blood glucose and fasting insulin levels used to estimate a person's degree of insulin resistance; lower values indicate better insulin sensitivity. (Homeostatic Model Assessment for Insulin ResistanceInsulin resistance is when your cells stop responding well to insulin, so your pancreas has to pump out more and more to do the same job.) scores.[1] This baseline, intrinsic systemic dysfunction elegantly explains why even strict human vegetarians and vegans—who consume absolutely zero red meat and often lack traditional risk factors like high cholesterol—remain significantly more prone to unexplained heart attacks and strokesA stroke happens when blood flow to part of the brain stops, either from a blockage or from bleeding. than captive chimpanzees with poor diets.[1,2] We are genetically wired for higher inflammation.

The Extrinsic Risk (The Red Meat Penalty)

In the critical second phase of the study, researchers sought to replicate the full, compounding mechanism of human red meat consumption and xenosialitis. They first immunized the human-like Cmah^-/- mice with specialized Neu5Gc-bearing antigens (utilizing complete Freund’s adjuvant) to generate circulating, affinity-matured anti-Neu5Gc antibodies, perfectly mimicking the human immune profile developed after weaning.[1] Subsequently, these immunized, humanized mice were fed a high-fat diet specifically enriched with high levels of Neu5Gc (mimicking a heavy, sustained red meat diet).[1]

The pathological results were dramatic and unequivocal. The immunized, Neu5Gc-fed mice suffered a massive 2.4-fold increase in the severity of atherosclerosis compared to control mice fed either a Neu5Ac-rich or a completely Sias-free high-fat diet.[1] Rigorous quantification of the aortic atherosclerosis was conducted: mice were euthanized, perfused, and their aortas dissected and pinned flat. Staining with Sudan IV to measure total lipid burden, alongside serial cryosections of the aortic sinus stained with Masson’s trichrome, revealed substantially more advanced lesionsIn cardiology, a lesion refers to a discrete area of atherosclerotic plaque narrowing a coronary artery, typically described by the percentage of luminal obstruction it causes. The article describes four residual lesions too small in vessel diameter to accept a stent after the most critical one was treated., highly expansive necrotic core areas, and dense, pathological collagen fiberFiber is the part of plant food your body cannot digest. It is found in beans, oats, vegetables, fruit, and whole grains. deposition.[1]

Critically, this aggressive 2.4-fold acceleration of plaque formation could not be explained by downstream changes in blood lipoprotein levels, total cholesterolTotal cholesterol adds together the cholesterol in all your particles, harmful and helpful alike. parameters, or glucoseGlucose is the sugar your blood carries to fuel your cells. metrics.[1] The blood lipids remained virtually identical between the experimental cohorts; the massive cardiovascular destruction was entirely, explicitly driven by the localized, antibody-mediated inflammatory destruction of the endothelium—the pure, unadulterated manifestation of xenosialitis.[1]

Clinical Correlates and Broader Systemic Pathologies

The insidious nature of Neu5Gc integration and subsequent xenosialitis extends far beyond the microscopic parameters of isolated mouse models; it manifests broadly in observable clinical phenomena and contributes to a wide spectrum of human systemic pathologies. The mechanism is not isolated to the major coronary arteriesThe coronary arteries are the small vessels that wrap around the outside of your heart and feed the heart muscle itself. but affects the entire vascular tree.

Diagnostic Indicators: Frank’s Sign and Microvascular Degradation

The systemic, ubiquitous nature of the endothelial damage caused by xenosialitis may actually be reflected in highly visible, external microvascular beds. Clinically, the presence of a diagonal earlobe crease (DELC)—known eponymously in medical literature as Frank’s sign—has been firmly and repeatedly established as an independent predictorA variable that statistically forecasts an outcome—such as mortality—even after accounting for other known risk factors like age, BMI, and cholesterol through multivariable analysis. of coronary artery diseaseCoronary artery disease is plaque buildup in the arteries feeding the heart muscle. and peripheral vascular disease.[25,26] This correlation holds true entirely independent of commonly known risk factors such as hypertension, diabetes, hyperlipidemia, and smoking.[25,26]

The underlying etiology of Frank’s sign is heavily hypothesized to be a parallel process of systemic microvascular disease and the accelerated, age-related weakening of elastinElastin is a structural protein in the arterial wall that allows blood vessels to stretch and recoil with each heartbeat; with age it degrades and is replaced by stiffer collagen, contributing to arterial stiffening and rising systolic blood pressure. and collagen fibers occurring simultaneously in both the vascular beds of the earlobe and the coronary arteries.[25,26] Given the wide systemic distribution of Neu5Gc in the human glycocalyx, particularly in dense microvasculature, the chronic, low-grade inflammation of xenosialitis likely accelerates this precise mechanism of microvascular degradation.[5] The continuous immune complex formation and complement deposition degrade the delicate collagen-elastin ratio, providing a highly plausible, unifying biochemical link to this visible, macroscopic diagnostic marker.[25,26]

Circulating Antibodies and Acute Systemic Vasculitis

The pathogenic potential of anti-Neu5Gc antibodies is further evidenced in acute, devastating human vascular diseases. Elevated titers of anti-Neu5Gc antibodies are prominently and consistently observed in Kawasaki disease, an acute, febrile, and often severe childhood systemic vasculitis that primarily affects the coronary arteries.[24] Notably, higher circulating antibody levels are detected in patients exhibiting morphologically normal coronary arteries compared to those suffering from severe, late-stage complications like massive aneurysms or dilated coronaries.[24] This seemingly inverse correlation suggests a consumptive pathogenesis: during acute, massive inflammatory phases, large volumes of circulating anti-Neu5Gc antibodies may be rapidly consumed, binding heavily and sequestering at the sites of active vascular damage in the coronary walls. This effectively lowers the measurable circulating titer in the blood draw while the antibodies actively drive the pathology deep within the arterial wall.[24]

Furthermore, elevated levels of IgA class antibodies specifically directed against dietary antigens have been directly identified in the sera of severely atherosclerotic subjects compared to highly selected, healthy controls.[27] This finding underscores the intimate, inseparable link between gut-derived dietary antigens, systemic immune hypersensitivity, and the ultimate arterial plaqueA deposit within the artery wall made up of lipids, immune cells, cellular debris, and fibrous tissue that accumulates over time and can narrow or block blood flow; also called an atherosclerotic lesion or atheroma. burden.[27] The mechanism is not confined to cardiovascular disease; the incorporation of Neu5Gc is also heavily implicated in cancer biology. Because Neu5Gc preferentially accumulates in malignant tissues due to rapid tumor growth rates, increased rates of micropinocytosis, and the hypoxic upregulation of the sialin transporter, xenosialitis provides a chronic inflammatory tumor microenvironment that directly promotes carcinogenesis, angiogenesisAngiogenesis is the sprouting of new capillaries from existing microvessels, driven primarily by tissue hypoxia through HIF-1α–mediated transcription of vascular endothelial growth factor (VEGF). Because capillaries lack a muscular wall, they improve local oxygen diffusion but cannot compensate for a significant obstruction in a large coronary artery., and metastasis.[8,22]

The Imminent Threat of Viral Cross-Reactivity

An emerging, highly critical area of study involves the interaction of the pre-existing xenosialitis paradigm with severe, acute viral infections. When humans mount massive, desperate antibody responses to enveloped viral pathogens (such as SARS-CoV-2 or Influenza A), the resulting neutralizing antiviral antibodies may inadvertently exacerbate underlying vascular disease.[15] Because enveloped viruses utilize the host’s own cellular glycosylation machinery to synthesize their viral envelopes, the newly formed virions become coated in whatever sialic acids the host cell is expressing.[15] In a human consuming red meat, these viral envelopes will be laced with Neu5Gc.[15]

Consequently, the massive wave of neutralizing antiviral antibodies produced during the infection may indiscriminately cross-react with xenosialylated (Neu5Gc-containing) epitopes scattered across the host’s own healthy endothelial tissues.[15] This massive, systemic antibody cross-reactivity has the potential to supercharge the pre-existing state of xenosialitis.[15] The resulting hyper-inflammatory storm leads to severe, disseminated coagulopathies, fatal cytokine storms, and profound, widespread endothelial damage.[15] This hypothesis elegantly explains why baseline cardiovascular health and dietary habits are such profound, overriding determinants of mortality during acute viral respiratory syndromes, as the viral infection essentially ignites the latent powder keg of diet-induced xenosialitis.[15]

Therapeutic Interventions and Future Scientific Horizons

Understanding the intricate mechanics of Neu5Gc integration not only resolves a massive evolutionary and epidemiological puzzle but also opens highly novel, actionable therapeutic avenues. These interventions aim to actively mitigate cardiovascular risk beyond the current paradigm of traditional statinA statin slows the enzyme your liver uses to make cholesterol. Your liver responds by pulling more cholesterol out of your blood, which is where the real benefit comes from. therapy, platelet inhibition, and blood pressureBlood pressure is the force of blood pushing against your artery walls. It is written as two numbers, like 120/80. The top number is the pressure when your heart squeezes, the bottom is when it relaxes. management.

Dietary Sialic Acid Interventions and Competitive Inhibition

The most immediate, biologically sound intervention is the direct modulation of the dietary sialic acid profile. Experimental data unequivocally demonstrates that intervening in the biochemical pathway can rapidly halt or even reverse the atherosclerotic acceleration.[4] In the heavily validated Cmah^-/- human-like mouse model, simply switching the subjects from a Neu5Gc-rich high-fat diet to a Neu5Gc-free high-fat diet actively protected against accelerated atherogenesis.[4]

Remarkably, adding a massive, five-fold excess of Neu5Ac (the safe, endogenous human sialic acid) to a high-fat diet effectively outcompeted the dangerous Neu5Gc for cellular uptake and utilization, effectively mitigating the inflammatory risk.[4] Furthermore, feeding a Neu5Ac-enriched diet intrinsically protected against atherosclerosis in Ldlr^-/- mice even in the absolute absence of dietary Neu5Gc, provided the host possessed the human-like Cmah-null genetic background, suggesting that flooding the system with the “correct” sugar actively stabilizes the human endothelium.[4]

Sources of highly concentrated, bioavailable Neu5Ac are currently being aggressively investigated. Collocalia mucoid extracts, commonly known as edible bird’s nest, are extraordinarily rich in natural Neu5Ac.[4] Biochemical digestion studies show that proper culinary preparation, specifically controlling the stewing temperature, maximizes the breakdown of the high-molecular-weight glycopeptides within the nest into highly absorbable, low-molecular-weight free Neu5Ac fragments.[4] This optimizes its bioavailability, allowing it to enter the bloodstream in high concentrations to serve as a competitive inhibitor against dietary Neu5Gc.[4]

Microbiome Engineering and Industrial Enzymatic Cleavage

A second, highly innovative therapeutic horizon involves the direct manipulation of the food supply using the very biochemical mechanisms evolved by the gut microbiome. The recent discovery of specific bacterial sialidases (derived from Bacteroidales and Clostridiales) that exhibit an overwhelming, highly specific enzymatic preference for cleaving Neu5Gc over Neu5Ac presents a massive industrial and medical opportunity.[17]

These powerful enzymes, capable of efficiently liberating bound Neu5Gc from complex red meat glycoproteins, could be utilized in the industrial processing of meat products prior to retail sale.[17] By pre-treating mammalian red meat with these specific recombinant bacterial sialidases, the meat could be effectively “stripped” of bound Neu5Gc.[17] Because free, unbound Neu5Gc is poorly absorbed by the gut and is rapidly, safely cleared by the renal system through the urine, converting the dangerous, bound Neu5Gc into harmless, free Neu5Gc directly in the food matrixThe food matrix refers to the physical and chemical structure of a whole food—cell walls, fiber, protein networks—that surrounds and interacts with its nutrients; fats consumed within an intact food matrix, such as whole almonds versus almond oil, are absorbed more slowly and less completely than the same fats in extracted, purified form. could drastically reduce the risk of inflammatory diseases.[11,16] This approach would effectively sever the biochemical chain that leads to xenosialitis without requiring total population-level dietary abstinence from red meat.[17,20]

Conclusion

The profound intersection of evolutionary biology, intracellular glycosylation mechanics, immunology, and modern dietary habits provides a comprehensive, molecularly precise explanation for the uniquely human predisposition to cardiovascular disease. The human cardiovascular system operates under a permanent, intrinsic genetic penalty—the indelible legacy of the Alu-mediated CMAH pseudogenization that occurred millions of years ago. While this dramatic mutation likely saved our hominin ancestors from catastrophic, malaria-driven parasitic extinction, it left the modern human glycocalyx permanently altered and highly vulnerable.

The regular consumption of mammalian red meat introduces massive, unnatural quantities of the “lost” sialic acid, Neu5Gc, directly into the human gastrointestinal tract. There, specialized bacterial sialidases liberate the molecule, allowing it to be absorbed. Through a tragic case of molecular mimicry, the human cellular machinery indiscriminately incorporates this foreign glycan via the sialin transporter, covalently presenting it on the luminal surface of the vascular endothelium. Primed by early-life dietary exposure and continuous molecular scavenging by commensal pathogens like Nontypeable Haemophilus influenzae, the human immune system recognizes the altered endothelium as a foreign threat. The resulting relentless, lifelong barrage of polyclonal IgG and IgA antibodies triggers classical complement deposition, massive selectin expression, monocyte extravasation, and continuous, smoldering plaque formation.

This highly validated mechanism, termed xenosialitis, beautifully and completely explains the 15% of clinical atherosclerosis cases occurring in patients utterly devoid of traditional risk factors. It flawlessly accounts for the massive 2.4-fold acceleration of atherogenesis seen in controlled animal models upon red meat consumption, and it clarifies why chimpanzees—our closest evolutionary relatives with identical lipid profiles—remain immune to coronary atherosclerosis. Moving forward, interventions targeting competitive Neu5Ac supplementation and the industrial enzymatic cleavage of Neu5Gc from the food supply offer the unprecedented promise of nullifying this ancient evolutionary trade-off, fundamentally altering the landscape of cardiovascular preventative medicine and redefining our understanding of diet-induced pathology.

References

1. Kawanishi K, Dhar C, Do R, Varki N, Gordts PLSM, Varki A. Human species-specific loss of CMP-N-acetylneuraminic acid hydroxylase enhances atherosclerosis via intrinsic and extrinsic mechanisms. Proc Natl Acad Sci U S A. 2019;116(32):16036-16045. doi:10.1073/pnas.1902902116
2. Baldessari A, Snyder J, Ahrens J, Murnane R. Fatal myocardial fibrosis in an aged chimpanzee (Pan troglodytes).
3. Banda K, Gregg CJ, Chow R, Varki NM, Varki A. Metabolism of vertebrate amino sugars with N-glycolyl groups: mechanisms underlying gastrointestinal incorporation of the non-human sialic acid xeno-autoantigen N-glycolylneuraminic acid.
4. Kawanishi K, Coker JK, Grunddal KV, et al. Dietary Neu5Ac Intervention Protects Against Atherosclerosis Associated With Human-Like Neu5Gc Loss-Brief Report.
5. Dhar C, Sasmal A, Varki A. From “Serum Sickness” to “Xenosialitis”: Past, Present, and Future Significance of the Non-human Sialic Acid Neu5Gc.
6. Lewis AL, Chen X, Schnaar RL, Varki A. Sialic Acids and Other Nonulosonic Acids. In: Varki A, Cummings RD, Esko JD, et al., eds.
7. Varki A. Sialic acids in human health and disease.
8. Altman MO, Gagneux P. Absence of Neu5Gc and Presence of Anti-Neu5Gc Antibodies in Humans-An Evolutionary Perspective. Front Immunol. 2019;10:789. Published 2019 Apr 30. doi:10.3389/fimmu.2019.00789
9. Varki A. Colloquium paper: uniquely human evolution of sialic acid genetics and biology. Proc Natl Acad Sci U S A. 2010;107 Suppl 2(Suppl 2):8939-8946. doi:10.1073/pnas.0914634107
10. Padler-Karavani V, Yu H, Cao H, et al. Diversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: potential implications for disease. Glycobiology. 2008;18(10):818-830. doi:10.1093/glycob/cwn072
11. Bardor M, Nguyen DH, Diaz S, Varki A. Mechanism of uptake and incorporation of the non-human sialic acid N-glycolylneuraminic acid into human cells. J Biol Chem. 2005;280(6):4228-4237. doi:10.1074/jbc.M412040200
12. Varki A. Multiple changes in sialic acid biology during human evolution. Glycoconj J. 2009;26(3):231-245. doi:10.1007/s10719-008-9183-z
13. Dubois L, Pietrancosta N, Cabaye A, et al. Amino Acids Bearing Aromatic or Heteroaromatic Substituents as a New Class of Ligands for the Lysosomal Sialic Acid Transporter Sialin. J Med Chem. 2020;63(15):8231-8249. doi:10.1021/acs.jmedchem.9b02119
14. Apicella MA. Nontypeable Haemophilus influenzae: the role of N-acetyl-5-neuraminic acid in biology. Front Cell Infect Microbiol. 2012;2:19. Published 2012 Mar 13. doi:10.3389/fcimb.2012.00019
15. Taylor RE, Gregg CJ, Padler-Karavani V, et al. Novel mechanism for the generation of human xeno-autoantibodies against the nonhuman sialic acid N-glycolylneuraminic acid. J Exp Med. 2010;207(8):1637-1646. doi:10.1084/jem.20100575
16. Verheijen FW, Verbeek E, Aula N, et al. A new gene, encoding an anion transporter, is mutated in sialic acid storage diseases. Nat Genet. 1999;23(4):462-465. doi:10.1038/70585
17. Zaramela LS, Martino C, Alisson-Silva F, et al. Gut bacteria responding to dietary change encode sialidases that exhibit preference for red meat-associated carbohydrates. Nat Microbiol. 2019;4(12):2082-2089. doi:10.1038/s41564-019-0564-9
18. Padler-Karavani V, Hurtado-Ziola N, Pu M, et al. Human xeno-autoantibodies against a non-human sialic acid serve as novel serum biomarkers and immunotherapeutics in cancer. Cancer Res. 2011;71(9):3352-3363. doi:10.1158/0008-5472.CAN-10-4102
19. Vimr ER, Kalivoda KA, Deszo EL, Steenbergen SM. Diversity of microbial sialic acid metabolism. Microbiol Mol Biol Rev. 2004;68(1):132-153. doi:10.1128/MMBR.68.1.132-153.2004
20. Tailford LE, Crost EH, Kavanaugh D, Juge N. Mucin glycan foraging in the human gut microbiome. Front Genet. 2015;6:81. Published 2015 Mar 19. doi:10.3389/fgene.2015.00081
21. Samraj AN, Pearce OM, Läubli H, et al. A red meat-derived glycan promotes inflammation and cancer progression. Proc Natl Acad Sci U S A. 2015;112(2):542-547. doi:10.1073/pnas.1417508112
22. Hull SC, Mszar R, Ostfeld RJ, et al. Diet and Prevention of Cardiovascular Disease and Cancer: JACC: CardioOncology State-of-the-Art Review. JACC CardioOncol. 2025;7(6):649-667. doi:10.1016/j.jaccao.2025.07.008
23. Evrengül H, Dursunoğlu D, Kaftan A, et al. Bilateral diagonal earlobe crease and coronary artery disease: a significant association. Dermatology. 2004;209(4):271-275. doi:10.1159/000080847
24. Padler-Karavani V, Tremoulet AH, Yu H, Chen X, Burns JC, Varki A. A simple method for assessment of human anti-Neu5Gc antibodies applied to Kawasaki disease. PLoS One. 2013;8(3):e58443. doi:10.1371/journal.pone.0058443
25. Shmilovich H, Cheng VY, Rajani R, et al. Relation of diagonal ear lobe crease to the presence, extent, and severity of coronary artery disease determined by coronary computed tomography angiography. Am J Cardiol. 2012;109(9):1283-1287. doi:10.1016/j.amjcard.2011.12.024
26. Gakovic B, Neskovic SA, Vranic I, et al. The relationship of diagonal earlobe crease (Frank’s sign) and obstructive coronary artery disease in patients undergoing coronary angiography. Wien Klin Wochenschr. 2023;135(23-24):667-673. doi:10.1007/s00508-023-02297-y
27. Muscari A, Volta U, Bonazzi C, et al. Association of serum IgA antibodies to milk antigens with severe atherosclerosis. Atherosclerosis. 1989;77(2-3):251-256. doi:10.1016/0021-9150(89)90088-9